Codexis, Inc. (CDXS)Healthcare | Biotechnology | Redwood City, United States | NasdaqGS
1.59 USD
-0.07
(-4.217%) ⇩
(Aug. 28, 2026, 4 p.m.
EDT)
After hours: 1.61 +0.02 (1.258%) ⇧ (Aug. 28, 2026, 7:30 p.m. EDT) |
Hot Take ↕ | Aug. 22, 2026, 1:39 a.m. EDT
The investment case for Codexis is currently broken by a perfect storm of deteriorating fundamentals and aggressive capital dilution. The company is hemorrhaging cash, with operating cash flow turning deeply negative and free cash flow barely covering operational costs while revenue shrinks. This financial distress is forcing management to issue dilutive equity offerings, which has already triggered a sharp sell-off and reshaped the trading setup. While the balance sheet still holds some liquidity, the relentless burn rate and shrinking top line suggest the business model is struggling to generate sustainable value without constant capital injections. The massive gap between the current price and the analyst mean target is dangerous; it relies entirely on a turnaround that the current financials do not yet support. For investors, the risk of permanent capital loss due to continued dilution and operational failure outweighs the speculative potential of a recovery. |
| Model | MAE |
|---|---|
| AutoTheta ✓ | 0.216821 |
| AutoARIMA | 0.247853 |
| AutoETS | 0.251561 |
| MSTL | 0.255459 |
Forecast horizon: 45 days | Selected: AutoTheta
| Forecast Reliability | |
|---|---|
| Score | 33% |
| H-stat | 10.88 |
| Ljung-Box p | 0.000 |
| Jarque-Bera p | 0.101 |
| Excess Kurtosis | -1.43 |
| Attribute | Value |
|---|---|
| Sector | Healthcare |
| Debt to Equity Ratio | 220.241 |
| Revenue per Share | 0.857 |
| Market Cap | 174,114,176 |
| Forward P/E | -4.97 |
| Beta | 2.50 |
| Profit Margins | -39.55% |
| Website | https://www.codexis.com |
As of Aug. 22, 2026, 1:39 a.m. EDT: Speculators are positioning defensively with heavy out-of-the-money put volume at strikes significantly below current price (0.5 and 1.0), indicating a fear of further downside. Conversely, call activity is concentrated in the money at strikes above the current price (2.0 and 2.5), suggesting a speculative hope for a rebound to previous highs rather than immediate bullish momentum. The implied volatility skew shows elevated premiums for deep out-of-the-money puts compared to calls, reflecting asymmetric risk concerns.
| Attribute | Value |
|---|---|
| 52 Week Change | -0.3386454 |
| Address1 | 200 Penobscot Drive |
| All Time High | 42.01 |
| All Time Low | 0.96 |
| Ask | 2.09 |
| Ask Size | 2 |
| Audit Risk | 5 |
| Average Analyst Rating | 1.7 - Buy |
| Average Daily Volume10 Day | 1,123,180 |
| Average Daily Volume3 Month | 1,147,185 |
| Average Volume | 1,147,185 |
| Average Volume10Days | 1,123,180 |
| Beta | 2.504 |
| Bid | 1.19 |
| Bid Size | 2 |
| Board Risk | 5 |
| Book Value | 0.361 |
| City | Redwood City |
| Compensation As Of Epoch Date | 1,767,139,200 |
| Compensation Risk | 8 |
| Country | United States |
| Crypto Tradeable | 0 |
| Currency | USD |
| Current Price | 1.59 |
| Current Ratio | 3.059 |
| Custom Price Alert Confidence | HIGH |
| Date Short Interest | 1,786,665,600 |
| Day High | 1.68 |
| Day Low | 1.58 |
| Debt To Equity | 220.241 |
| Display Name | Codexis |
| Earnings Call Timestamp End | 1,786,480,200 |
| Earnings Call Timestamp Start | 1,786,480,200 |
| Earnings Timestamp | 1,786,478,400 |
| Earnings Timestamp End | 1,793,908,800 |
| Earnings Timestamp Start | 1,793,908,800 |
| Ebitda | -19,047,000 |
| Ebitda Margins | -0.24520001 |
| Enterprise To Ebitda | -10.069 |
| Enterprise To Revenue | 2.469 |
| Enterprise Value | 191,783,168 |
| Eps Current Year | -0.42 |
| Eps Forward | -0.32 |
| Eps Trailing Twelve Months | -0.32 |
| Esg Populated | 0 |
| Exchange | NMS |
| Exchange Data Delayed By | 0 |
| Exchange Timezone Name | America/New_York |
| Exchange Timezone Short Name | EDT |
| Fifty Day Average | 1.9392 |
| Fifty Day Average Change | -0.3492 |
| Fifty Day Average Change Percent | -0.18007426 |
| Fifty Two Week Change Percent | -33.86454 |
| Fifty Two Week High | 2.98 |
| Fifty Two Week High Change | -1.39 |
| Fifty Two Week High Change Percent | -0.46644294 |
| Fifty Two Week Low | 0.96 |
| Fifty Two Week Low Change | 0.63000005 |
| Fifty Two Week Low Change Percent | 0.65625006 |
| Fifty Two Week Range | 0.96 - 2.98 |
| Financial Currency | USD |
| First Trade Date Milliseconds | 1,271,943,000,000 |
| Float Shares | 82,348,335 |
| Forward Eps | -0.32 |
| Forward P E | -4.96875 |
| Free Cashflow | 2,129,750 |
| Full Exchange Name | NasdaqGS |
| Full Time Employees | 146 |
| Fullday Change | -0.0699999 |
| Fullday Change Percent | -4.21686 |
| Fullday Price | 1.61 |
| Gmt Off Set Milliseconds | -14,400,000 |
| Governance Epoch Date | 1,785,542,400 |
| Gross Margins | 0.24269 |
| Gross Profits | 18,852,000 |
| Has Pre Post Market Data | 1 |
| Held Percent Insiders | 0.07119 |
| Held Percent Institutions | 0.70435 |
| Implied Shares Outstanding | 109,505,765 |
| Industry | Biotechnology |
| Industry Disp | Biotechnology |
| Industry Key | biotechnology |
| Is Earnings Date Estimate | 0 |
| Language | en-US |
| Last Fiscal Year End | 1,767,139,200 |
| Long Business Summary | Codexis, Inc. provides technology solutions for therapeutics manufacturing, leveraging its proprietary CodeEvolver technology platform to discover, develop, enhance, and commercialize novel enzymes in the United States, Canada, Latin America, Europe, the Middle East, Africa, Australia, New Zealand, Southeast Asia, and China. The company develops its proprietary ECO Synthesis manufacturing platform to enable the scaled manufacture of RNAi therapeutics through an enzymatic route. It has a license agreement with Aldevron LLC and Pfizer Inc. The company was incorporated in 2002 and is headquartered in Redwood City, California. |
| Long Name | Codexis, Inc. |
| Market | us_market |
| Market Cap | 174,114,176 |
| Market State | CLOSED |
| Max Age | 86,400 |
| Message Board Id | finmb_3160285 |
| Most Recent Quarter | 1,782,777,600 |
| Net Income To Common | -30,723,000 |
| Next Fiscal Year End | 1,798,675,200 |
| Non Diluted Market Cap | 181,779,569 |
| Number Of Analyst Opinions | 6 |
| Open | 1.66 |
| Operating Cashflow | -10,404,000 |
| Operating Margins | -0.75287 |
| Overall Risk | 7 |
| Payout Ratio | 0.0 |
| Peg Ratio | 13.53 |
| Phone | 650 421 8100 |
| Post Market Change | 0.01999998 |
| Post Market Change Percent | 1.2578604 |
| Post Market Price | 1.61 |
| Post Market Time | 1,787,959,805 |
| Previous Close | 1.66 |
| Price Eps Current Year | -3.7857144 |
| Price Hint | 4 |
| Price To Book | 4.4044323 |
| Price To Sales Trailing12 Months | 2.2414575 |
| Profit Margins | -0.39551 |
| Quick Ratio | 2.831 |
| Quote Source Name | Nasdaq Real Time Price |
| Quote Type | EQUITY |
| Recommendation Key | buy |
| Recommendation Mean | 1.71429 |
| Region | US |
| Regular Market Change | -0.0699999 |
| Regular Market Change Percent | -4.21686 |
| Regular Market Day High | 1.68 |
| Regular Market Day Low | 1.58 |
| Regular Market Day Range | 1.58 - 1.68 |
| Regular Market Open | 1.66 |
| Regular Market Previous Close | 1.66 |
| Regular Market Price | 1.59 |
| Regular Market Time | 1,787,947,201 |
| Regular Market Volume | 634,418 |
| Return On Assets | -0.11738 |
| Return On Equity | -0.69361 |
| Revenue Growth | -0.027 |
| Revenue Per Share | 0.857 |
| Sand P52 Week Change | 0.20504117 |
| Sector | Healthcare |
| Sector Disp | Healthcare |
| Sector Key | healthcare |
| Share Holder Rights Risk | 8 |
| Shares Outstanding | 109,505,765 |
| Shares Percent Shares Out | 0.034 |
| Shares Short | 3,724,621 |
| Shares Short Previous Month Date | 1,784,073,600 |
| Shares Short Prior Month | 3,748,739 |
| Short Name | Codexis, Inc. |
| Short Percent Of Float | 0.0344 |
| Short Ratio | 2.49 |
| Source Interval | 15 |
| State | CA |
| Symbol | CDXS |
| Target High Price | 11.0 |
| Target Low Price | 2.0 |
| Target Mean Price | 6.33333 |
| Target Median Price | 6.5 |
| Total Cash | 54,918,000 |
| Total Cash Per Share | 0.502 |
| Total Debt | 72,587,000 |
| Total Revenue | 77,679,000 |
| Tradeable | 0 |
| Trailing Annual Dividend Rate | 0.0 |
| Trailing Annual Dividend Yield | 0.0 |
| Trailing Eps | -0.32 |
| Trailing Peg Ratio | None |
| Triggerable | 1 |
| Two Hundred Day Average | 1.88865 |
| Two Hundred Day Average Change | -0.2986499 |
| Two Hundred Day Average Change Percent | -0.15812878 |
| Type Disp | Equity |
| Volume | 634,418 |
| Website | https://www.codexis.com |
| Zip | 94,063 |